| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |